
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium from pathogenic microorganisms, and to help for immune-system development. The liver is the front-line organ that receives gut-derived products through the portal vein, implying that the liver could be severely affected by a disrupted intestinal homeostasis. Indeed, some liver diseases like alcoholic liver disease are associated with an altered composition of gut microbiota and increased blood endotoxin levels. Therefore, deficiency of SIgA function appears as a significant factor for the pathogenesis of liver diseases associated with altered gut microbiome. In this review, we describe SIgA functions on the gut microbiome and discuss the role of IgA for liver diseases, especially alcoholic liver disease and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
1.1 Normal biological development and functioning, Clinical Sciences, Chronic Liver Disease and Cirrhosis, 610, Clinical sciences, Review, Oral and gastrointestinal, Hepatitis, Alcohol Use and Health, Substance Misuse, Underpinning research, Non-alcoholic Fatty Liver Disease, NAFLD, 616, 2.1 Biological and endogenous factors, Humans, Aetiology, Liver Diseases, Alcoholic, Nutrition, Gut microbiome, Biomedical and Clinical Sciences, Gastroenterology & Hepatology, Liver Disease, Inflammatory and immune system, Liver Diseases, NASH, Secretory, Alcoholic, Immunoglobulin A, Gastrointestinal Microbiome, Intestines, Alcoholism, Good Health and Well Being, ALD, Immunoglobulin A, Secretory, Digestive Diseases, IgA
1.1 Normal biological development and functioning, Clinical Sciences, Chronic Liver Disease and Cirrhosis, 610, Clinical sciences, Review, Oral and gastrointestinal, Hepatitis, Alcohol Use and Health, Substance Misuse, Underpinning research, Non-alcoholic Fatty Liver Disease, NAFLD, 616, 2.1 Biological and endogenous factors, Humans, Aetiology, Liver Diseases, Alcoholic, Nutrition, Gut microbiome, Biomedical and Clinical Sciences, Gastroenterology & Hepatology, Liver Disease, Inflammatory and immune system, Liver Diseases, NASH, Secretory, Alcoholic, Immunoglobulin A, Gastrointestinal Microbiome, Intestines, Alcoholism, Good Health and Well Being, ALD, Immunoglobulin A, Secretory, Digestive Diseases, IgA
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 55 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
